Calprotectin is an abundant neutrophil cytosolic protein released during neutrophil activation or death.
The prognosis in cystic fibrosis is largely dependent on the incidence, severity, and duration of pulmonary infections.' Infections cause cumulative lung damage which increases susceptibility to further infection. The lung damage is largely the result of local inflammation associated with bacterial invasion. The dominant cells in this type of inflammation are neutrophils. Enormous numbers of these are mobilised, then activated and killed at the sites of invasion in the lungs. Thus, early in the course of infection, neutrophil turnover increases rapidly.
To improve the prognosis in cystic fibrosis requires early, effective treatment and sex matched to 1-4 cystic fibrosis subjects, were also studied just before minor surgery, mainly insertion or removal of grommets. The children and their parents were fully informed about the study and parents gave their written consent. The study was approved by the joint ethics committee of the Grampian Health Board and Aberdeen Royal Hospitals Trust.
The cystic fibrosis group had an array of clinical and laboratory tests which included a requirement for peripheral venepuncture. This was performed first. An extra 3 ml blood sample was taken. Of this sample, 2 ml was anticoagulated with 40 ,ul 0-I M EDTA for the calprotectin assay, 1 ml with 30 units of heparin for trace element assays and microbiological experiments (to be reported later). Both subsamples were centrifuged at 1500 g for 10 minutes and the top two thirds of plasma was gently aspirated and stored at -20°C before analysis.
Calprotectin was measured, in duplicate, by a non-competitive enzyme linked immunoassay. 15 Briefly, 50 ,ul alkaline phosphatase conjugated anticalprotectin was incubated with 50 ,ll sample or standard (in duplicate, and diluted 1 in 50) in microtitre wells coated with an IgG fraction of a rabbit polyclonal anticalprotectin antibody. After washing and addition of substrate, p-nitrophenyl phosphate, the optical densities of the samples and standards were determined at 410 nm on a Minireader II (Dynatech). There was a linear correlation between optical density and calprotectin concentration up to 15 000 pug/l; samples giving higher optical densities were further diluted and reassayed. Calculations were performed using the advanced applications programme on Minireader II. Immunopurified calprotectin stock standard (28 mg/l), the polyclonal antibody, and the alkaline phosphatase conjugated antibody were prepared in Oslo.
Plasma zinc and copper concentrations were measured in EDTA samples diluted 1 in 10 with 1% nitric acid (Aristar grade) by atomic absorption spectrophotometry (Pye Unicam SP9) at the Rowett Research Institute.
Plasma calprotectin, zinc, and copper were measured in all subjects in both groups, cystic fibrosis and control. In the cystic fibrosis group, total and differential leucocyte count, serum C reactive protein, and immunoglobulins were measured and liver function tests, sputum culture, and chest radiography were also performed as part of their annual review.
In the control group, total and differential leucocyte counts were performed in 13 of the 17 subjects.
Results
None of the children in either group was pyrexic. None of the control group had clinical signs of infection or other evidence of inflammation: in the 13 tested, total and differential leucocyte counts were normal.
All of the cystic fibrosis children were in their 'usual' state of health; none felt acutely unwell. Nineteen were receiving oral antibiotics; five, inhaled antibiotics; and eight, no antibiotics. Fifteen said they never produced sputum unaided. Sputum culture was positive in 21 of 27 samples obtained, of which 16 grew Staphylococcus aureus; 10, Pseudomonas aeruginosa; two, Haemophilus influenzae; one, Pseudomonas cepacia; three, Candida spp; and one, Aspergillus fumigatus. All of the cystic fibrosis children had abnormal chest radiographs. Out of a maximum possible Northern score3 of 20 ((0-4) per lung quadrant+ (0-4)), their median score was 10 (range 5-16); six had a score of 3 (that is, 'severe' changes) in at least one quadrant. Nevertheless, none of the cystic fibrosis children had a raised leucocyte count (range 3-8-13-0x 109/l), only one child had a neutrophil count over 7 0x109/l (range 1*7-10*3X 109/1), and only four children had a serum C reactive protein concentration over 1 mg/l (range < 1-2 2 mg/l). Two children had slightly raised serum IgG, 17-4 and 18-9 g/l, and the latter child had raised serum IgA, [4] [5] [6] g/l; none had raised serum IgM concentration. One child, with a serum C reactive protein of 2-2 mg/l, had a low plasma zinc, 9 pLmo1/l, and high plasma copper, 27 ,umol/l; each of these is evidence of possible acute phase response. His sputum grew S aureus. Seven children had raised serum activities of both alanine aminotransferase (51-168 U/1) and y-glutamyltransferase (61-259 U/1).
Plasma calprotectin concentration in the control group was 321-1657 ,ug/l (median 727 ptg/l, mean 708 ,ug/l; 95% confidence interval 320 to 1570 ,ug/l). In the cystic fibrosis group, it was 417-25 850 p,g/l (median 1832 ,ug/l).
For further analyses, all calprotectin data were log10 transformed to obtain normal distributions. Plasma calprotectin was significantly higher in the cystic fibrosis group than in the control group (paired t test, p<0-0001) but there was considerable overlap (fig 1) . Sixteen of the 31 cystic fibrosis children had values above the control range. Plasma calprotectin did not change with age in the control group. However, it tended to increase with age (r=0 32, p=0 08) in the cystic fibrosis group. One patient, under 7 Using age and Northern score as independent variables in a stepwise multiple regression, age lost its effect and Northern score became the only predictor. Figure 3 shows acute phase response. Chest radiographs carry a cumulative risk so cannot be repeated frequently; even serial radiographs usually do not allow distinction between acute infection and chronic changes. In this study, they were all abnormal and it was not possible to distinguish those with and without signs of ongoing infection. The Northern score of those with positive sputum culture was slightly but insignificantly higher than those with sterile sputum (mean 7 9 v 5-8 respectively); its predictive value was too low to be useful. However, their Northern score was associated with their plasma calprotectin, which suggests that the latter is related to the extent of lung involvement. There was no association among the acute phase response indices measured (leucocyte and neutrophil counts, C reactive protein, plasma zinc and copper) within children, except in one whose serum C reactive protein and plasma copper were raised and plasma zinc was low. His mucopurulent sputum grew S aureus, his Northern score was 13, but his leucocyte and neutrophil counts were normal. Of the four children with slightly raised C reactive protein values, two had positive and one had negative sputum culture; the fourth did not produce sputum. The child with the highest Northern score, of 16, was the only one with raised serum IgG and IgA; his purulent sputum grew S aureus and P aeruginosa but none of the measured acute phase response indices was raised. Thus, none and no combination of the usual objective measures of infection appeared to discriminate between infected and non-infected children in this study. Recently, however, in six adults with cystic fibrosis, Elborn et al demonstrated significant though variable responses in both serum C reactive protein and neutrophil elastase alantitrypsin complex at the time of first culture of P aeruginosa in sputum.17 Thereafter, these acute phase response indices decreased again but the elastase complex remained significantly raised at least until specific antibodies appeared. Like calprotectin, this complex is a neutrophil product whose assay is not yet generally available. Sputum from 10 of our patients grew Pseudomonas spp. They were older than the rest (mean 1 2 5 v 9 0 years) and their Northern scores were higher (mean 9 4 v 6 0). However, just one of them had raised serum C reactive protein while six had raised plasma calprotectin compared with 10 of the remaining 21 patients whose sputum did not grow Pseudomonas spp.
Overall, plasma calprotectin was clearly raised in the children with cystic fibrosis compared with their matched controls. It was associated with the Northern score, a measure of lung involvement. It was also associated with their plasma copper concentration. In most if not all situations, this reflects plasma caeruloplasmin,18 a copper dependent ferroxidase exported from the liver as part of the acute phase response. Thus, plasma calprotectin is also associated with the acute phase response. Seven children had laboratory evidence of hepatic pathology, presumably inflammation because of bile stagnation or obstruction.
There was a weak association between y-glutamyltransferase and plasma calprotectin. Thus, it would appear that hepatic pathology is a confounding variable. Treatment of pulmonary and hepatic inflammation may be different. This is a potential drawback to the use of plasma calprotectin as a measure of pulmonary inflammation.
In conclusion, the data suggest that plasma calprotectin is reflecting the extent of ongoing inflammation in patients with cystic fibrosis. They also suggest the need for further studies to test its usefulness in assessing the need for antibiotic treatment.
